Expression of HGF/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas.

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma. Clin Cancer Res (2009) 1.49

c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. Ann Oncol (2012) 1.33

MET as a target for treatment of chest tumors. Lung Cancer (2008) 1.29

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer (2005) 1.12

Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. Mol Cancer Ther (2014) 1.01

Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget (2015) 0.88

Met in urological cancers. Cancers (Basel) (2014) 0.77

Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas. Int J Clin Exp Pathol (2014) 0.76

Linking the history of radiation biology to the hallmarks of cancer. Radiat Res (2014) 0.76

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer (2009) 4.45

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene (2005) 4.07

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J (2005) 2.60

Echocardiographic epicardial fat thickness and coronary artery disease. Circ J (2007) 2.40

Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol (2010) 2.27

Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol (2008) 2.18

Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia. Eur Respir J (2012) 2.10

12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol (2010) 2.02

Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol (2003) 2.02

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin Cancer Res (2006) 1.98

Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res (2008) 1.90

Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS (2005) 1.77

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.70

Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS (2007) 1.62

Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol (2006) 1.62

Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology (2003) 1.56

Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology (2013) 1.49

Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology (2005) 1.48

Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47

Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer (2006) 1.38

Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol (2009) 1.37

Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res (2007) 1.35

Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer (2012) 1.33

Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood (2002) 1.30

Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice. PLoS One (2009) 1.28

BRAF and KRAS mutations in stomach cancer. Oncogene (2003) 1.27

Genetic alterations of the KLF6 gene in gastric cancer. Oncogene (2005) 1.26

Whole transcriptome analyses of six thoroughbred horses before and after exercise using RNA-Seq. BMC Genomics (2012) 1.26

Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology (2012) 1.24

Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun (2002) 1.23

ArrayCyGHt: a web application for analysis and visualization of array-CGH data. Bioinformatics (2005) 1.23

Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23

Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract (2006) 1.23

T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci (2012) 1.21

The role of metastasis suppressor genes in metastatic dormancy. APMIS (2008) 1.21

CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res (2005) 1.20

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch (2005) 1.20

Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. APMIS (2007) 1.20